SHANGHAI BRIGHT BAOSHI EYE HOSPITAL
SHANGHAI BRIGHT BAOSHI EYE HOSPITAL — Shanghai
Hospital Profile
Shanghai Purui BaoShi Ophthalmology Hospital (Shanghai Purui Ophthalmology Baoshan Branch / Shanghai University of Health Sciences Affiliated Purui BaoShi Ophthalmology Hospital) is located at No. 1788 Changjiang West Road, Baoshan District, Shanghai. It is a tertiary/secondary large-scale comprehensive ophthalmology hospital under the A-share listed company Purui Ophthalmology Group, integrating medical treatment, teaching, scientific research, and blindness prevention. It fills the gap of specialty eye hospitals in northern Shanghai, with services covering Baoshan, Jing'an, Putuo, Hongkou, and areas such as Fengxian and Changning. As an affiliated hospital of Shanghai University of Health Sciences, relying on the integration advantages of medical education and research from the university, it has been selected as a recommended private institution specializing in SMILE surgery and high myopia correction in Shanghai.
Medical Milestones
• 2026: Took the lead in introducing Zeiss's new generation VISUMAX 800 femtosecond laser system, and fully launched EVO ICL (V5) lens implantation surgery along with a three-level review lens calculation center. • To date: The group has established 40 chain institutions across 26 cities nationwide; the Baoshan campus has more than 40 actual open beds, the refractive team has completed over 10,000 refractive surgeries, with more than 5,000 ICL surgeries, supporting lifetime free follow-ups at different locations across the country.
Key Capabilities & Patient Care
Adhering to the service concept of 'patient-centered care,' we provide an all-inclusive transparent pricing system (more than 30 preoperative examinations and nationwide follow-up checks are free, with no hidden costs), and offer expedited channels for military recruits and subsidies for students. We have innovatively established a high myopia MDT multidisciplinary consultation (joint evaluation by the refractive and retinal departments) and an in-hospital exclusive lens calculation center (implementing a three-level review mechanism), and fully promote free follow-up checks in different locations as well as weekend/no-holiday clinics.
Advanced Technology
The building covers approximately more than 7,000 square meters and is equipped with instruments including the ZEISS VISUMAX 800 femtosecond laser, ZEISS ARTEVO 800 intraoperative real-time OCT navigation microscope, ZEISS CIRRUS HD-OCT 5000, and the Smart Armas all-laser system. It is proficient in performing SMILE pro femtosecond laser surgery (ultra-fast 10-second cutting), single-incision, no-viscoelastic 'one-step' EVO ICL (V5) lens implantation, fine correction of astigmatism, and treatment of complex fundus diseases/cataracts. Statistics: • Bed capacity: The building covers over 7,000 square meters, with more than 40 actual beds in use • Department count: 5 core departments: Refractive Surgery, Cataract/Glaucoma & Ocular Surface, Retina, Optometry & Pediatric Ophthalmology, Dry Eye; scheduled to be designated as a 'Clinical Demonstration Center for Precise Myopia Prevention and Treatment' in 2026 (established jointly by the Chinese National Health Association × Fudan ENT & Ophthalmology × ZEISS in 2026) • Number of full-time physicians: Over 100 professional medical and expert staff; the exact number of physicians is not disclosed • Number of multi-site practitioners/specially invited experts: Led by Director Zhang Xiaolin (Head of Refractive Surgery in Shanghai), Deputy Director Xiao Qirui (double-certified expert, ESCRS member), Dr. Chen Weicun (Fudan graduate, trained under Professor Zhou Xingtao), and Professor Wang Hao (visiting scholar at Harvard Medical School); total number not disclosed • Annual outpatient visit volume: Not disclosed (supports full-week and weekend clinics, quick surgical scheduling within 1–5 days) • Surgical capacity: The refractive team has performed over 10,000 surgeries; Deputy Director Xiao Qirui has performed over 5,000 ICL procedures; proficient in SMILE pro femtosecond laser, 'one-step' EVO ICL (V5), fine correction of astigmatism, as well as complex fundus disease/cataract treatment; ZEISS VISUMAX 800 will be introduced in 2026 • International certification and qualifications: Designated hospital for Shanghai municipal medical insurance (2024); secondary-level specialized ophthalmic hospital (2026); part of the A-share listed company Purui Eye Hospital Group (301239); affiliated with Shanghai University of Medicine & Health; first in 2026 to introduce ZEISS VISUMAX 800 • International services: 40 branches across 26 cities nationwide with free follow-up in remote locations; 'one city, three hospitals' layout (Changning/Fengxian/Baoshan, 2026)
International Patient Services
The expert team has an international academic background (for example, Professor Wang Hao once visited Harvard Medical School's Massachusetts Eye and Ear Hospital for study, and Deputy Director Xiao Qirui is a member of the European Society of Cataract and Refractive Surgeons); they have introduced top international imported equipment such as Zeiss and Orbis, and have the technical capability to provide medical consultations for international patients and cross-regional multilingual services.